Magnesium Sulfate Sterop

Magnesium sulfate, the active ingredient in Magnesium Sulfate Sterop, is a magnesium salt presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to correct magnesium deficiency and to manage conditions such as pre‑eclampsia/eclampsia, torsades de pointes, severe asthma exacerbations, and cardiac arrhythmias by restoring electrolyte balance and providing vasodilatory and neuromuscular effects.

GNH USA supplies Magnesium Sulfate Sterop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium Sulfate Sterop is used in several electrolyte‑related and cardiovascular conditions where magnesium supplementation is required.

- Magnesium deficiency: restores normal magnesium concentrations and supports overall electrolyte homeostasis. - Pre‑eclampsia/eclampsia: prevents seizures by stabilising neuronal excitability in pregnant patients. - Torsades de pointes: terminates this polymorphic ventricular tachycardia through calcium antagonism. - Severe asthma exacerbations: promotes bronchodilation and reduces airway hyper‑responsiveness. - Cardiac arrhythmias: assists in the management of various rhythm disturbances by modulating cardiac conduction.

Adverse reactions may occur with magnesium sulfate administration and are categorized by frequency.

Common Side Effects: - Flushing or feeling of warmth. - Nausea or vomiting. - Hypotension or mild dizziness. - Injection‑site pain or irritation. - Muscle weakness or fatigue.

Serious or Rare Side Effects: - Respiratory depression or apnea. - Severe hypotension leading to shock. - Cardiac arrest or profound bradyarrhythmia. - Hypermagnesemia with neuromuscular blockade. - Anaphylactic or severe allergic reactions.

Magnesium Sulfate Sterop requires careful monitoring in specific patient populations and clinical situations.

- Renal impairment: monitor serum magnesium levels closely to avoid accumulation. - Cardiac disease: use cautiously and observe ECG for conduction changes. - Neuromuscular disorders: increased risk of prolonged muscle relaxation. - Pregnancy: limited data; weigh maternal benefits against potential fetal effects. - Concomitant calcium channel blockers: heightened vasodilatory response may occur. - Store at ambient temperature: keep in original container, protect from light and moisture.

Magnesium sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilation may cause severe hypotension. - Neuromuscular blocking agents: potentiation of blockade leading to prolonged paralysis. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increased renal magnesium loss may require dose adjustment. - ACE inhibitors or ARBs: combined effect on electrolyte balance warrants monitoring. - Aminoglycoside antibiotics: potential for enhanced neuromuscular toxicity.